ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Matching, Outcomes and Costs in Substance Abuse/Psychiatric Treatment

This study has been completed.

Sponsored by: Department of Veterans Affairs
Information provided by: Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00012727
  Purpose

This project�s goal is to improve the quality of care and reduce treatment costs for veterans with substance abuse and psychiatric problems.


Condition Intervention Phase
Dual Diagnosis
Procedure: Matching Symptom Severity to Service Intensity
Phase II

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title:   Matching, Outcomes and Costs in Substance Abuse/Psychiatric Treatment

Further study details as provided by Department of Veterans Affairs:

Estimated Enrollment:   236
Study Completion Date:   August 2001

Arms Assigned Interventions
1 Procedure: Matching Symptom Severity to Service Intensity

Detailed Description:

Background:

This project�s goal is to improve the quality of care and reduce treatment costs for veterans with substance abuse and psychiatric problems.

Objectives:

This project is evaluating a patient-treatment matching strategy to improve residential treatment for substance abuse patients with psychiatric disorders. Its immediate objective is to examine whether the matching strategy results in more effective and cost-effective treatment in VA programs. We hypothesize that patients with severe clinical problems will have better outcomes when they are matched to service-intensive programs; patients with moderate problems will have better outcomes when they are matched to programs having a lower intensity of services. For both patient groups, community treatment should prove to be more cost-effective than hospital treatment.

Methods:

The project utilized a stratified randomized design. We paired each of three VA hospital programs that treat dual diagnosis patients and are high on intensity with a nearby high-intensity community residential facility (CRF) that contracts with the VA. We also paired four VA hospital and four CRFs that are low on intensity. Veterans who applied for substance abuse treatment at VA facilities were randomly assigned to either the VA hospital or CRF. Patient assessments have been conducted at intake (N=230), discharge, and a 4-month follow-up. Primary outcomes are patients� severity of substance abuse and psychiatric problems. Secondary outcomes are patients� functional status and their VA and non-VA health care utilization and its costs.

Status:

Completed.

  Eligibility
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

Patients must be entering a VA inpatient substance abuse or psychiatric treatment program and be clinically judged as appropriate for inpatient or community residential care.

Exclusion Criteria:

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00012727

Locations
United States, California
VA Palo Alto Health Care System    
      Palo Alto, California, United States, 94304-1207
VA Long Beach Health Care System    
      Long Beach, California, United States, 90822-5201
VA Palo Alto Health Care System    
      Menlo Park, California, United States, 94025
United States, Florida
North Florida/South Georgia Veterans Health System    
      Gainesville, Florida, United States, 32608
United States, Nebraska
VA NE-Western IA Health Care System    
      Omaha, Nebraska, United States, 68105-1873
United States, Oklahoma
VA Medical Center    
      Oklahoma City, Oklahoma, United States, 73104
United States, Pennsylvania
VA Pittsburgh Health Care System    
      Pittsburgh, Pennsylvania, United States, 15240
United States, Virginia
VA Medical Center    
      Hampton, Virginia, United States, 23667

Sponsors and Collaborators

Investigators
Principal Investigator:     Christine Timko, PhD     VA Palo Alto Health Care System    
  More Information


Publications of Results:

Responsible Party:   Department of Veterans Affairs ( Timko, Christine - Principal Investigator )
Study ID Numbers:   IIR 95-011
First Received:   March 14, 2001
Last Updated:   August 14, 2008
ClinicalTrials.gov Identifier:   NCT00012727
Health Authority:   United States: Federal Government

Study placed in the following topic categories:
Mental Disorders
Substance-Related Disorders
Disorders of Environmental Origin

ClinicalTrials.gov processed this record on October 15, 2008




Links to all studies - primarily for crawlers